The Rett Syndrome Research Trust (RSRT) is delighted to announce that Randall L. Carpenter is joining the organization in the role of Chief Scientific Officer. In this newly created position, Dr. Carpenter, who will start on March 1, will be responsible for accelerating the translation of basic science discoveries into medications that will profoundly improve the lives of individuals with Rett Syndrome and MECP2 disorders.
(PRWeb February 25, 2016)
Read the full story at http://www.prweb.com/releases/2016/02/prweb13230397.htm
For more information, please visit
http://www.prweb.com/releases/2016/02/prweb13230397.htm